Literature DB >> 26168861

Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.

Anna Beltrame1,2, Sergio Venturini3, Giovanni Crichiutti4, Valeria Meroni5, Dora Buonfrate6, Matteo Bassetti3.   

Abstract

INTRODUCTION: We report an unusual case of acute acquired toxoplasmosis (AAT) presenting as lymphadenopathy and recurrent seizures in an immunocompetent 15-year-old boy.
MATERIALS AND METHODS: The patient reported an 18-day vacation to Africa (Ethiopia), 39 days prior to the first seizure. Electroencephalogram (EEG) showed sporadic single-spike or sharp-wave paroxysms and the magnetic resonance imaging (RMI) of the brain was negative. The serology for T. gondii was compatible with an acute infection defined as positive for both toxoplasma-specific IgG and IgM and a low avidity (6 %), confirmed by a reference laboratory. The patient reported other two episodes of seizures, occurring 7 days apart. He was treated with pyrimethamine plus sulfadiazine and leucovorin for 4 weeks, with an improvement of lymphadenitis and normalization of EEG. After 5 months, new seizures were reported and a diagnosis of epilepsy was done. Toxoplasma polymerase chain reaction (PCR) of cerebrospinal fluid (CSF) and blood were negative. A treatment with valproic acid was started, obtaining control of the neurological disease.
CONCLUSION: Awareness of this neurologic manifestation by clinicians is required, also in immunocompetent patients. The relationship between toxoplasmosis and recurrent seizure needs to be investigated by new studies.

Entities:  

Keywords:  Acute acquired toxoplasmosis; Immunocompetent; Seizure; Toxoplasma gondii; Travel

Mesh:

Substances:

Year:  2015        PMID: 26168861     DOI: 10.1007/s15010-015-0821-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana.

Authors:  M Demar; D Hommel; F Djossou; C Peneau; R Boukhari; D Louvel; A-M Bourbigot; V Nasser; D Ajzenberg; M-L Darde; B Carme
Journal:  Clin Microbiol Infect       Date:  2011-09-29       Impact factor: 8.067

2.  What are the respective host and parasite contributions to toxoplasmosis?

Authors:  Danièle Maubon; Daniel Ajzenberg; Marie-Pierre Brenier-Pinchart; Marie-Laure Dardé; Hervé Pelloux
Journal:  Trends Parasitol       Date:  2008-05-29

3.  Acquired toxoplasmosis accompanied by facial nerve palsy in an immunocompetent 5-year-old child.

Authors:  Assimina Galli-Tsinopoulou; Ioannis Kyrgios; Eleni Z Giannopoulou; Styliani Gourgoulia; Ioanna Maggana; Elina Katechaki; Dimitrios Chatzidimitriou; Athanasios E Evangeliou
Journal:  J Child Neurol       Date:  2010-12       Impact factor: 1.987

4.  Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient.

Authors:  Elizabeth de Souza Neves; Andrea Kropf; Wendy Fernandes Bueno; Isabel Cristina Fabregas Bonna; André Luis Land Curi; Maria Regina R Amendoeira; Octavio Fernandes Filho
Journal:  Trop Doct       Date:  2010-11-09       Impact factor: 0.731

Review 5.  Mechanisms of Toxoplasma gondii persistence and latency.

Authors:  William J Sullivan; Victoria Jeffers
Journal:  FEMS Microbiol Rev       Date:  2011-10-04       Impact factor: 16.408

6.  Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon.

Authors:  Aurélien Mercier; Sébastien Devillard; Barthélémy Ngoubangoye; Henri Bonnabau; Anne-Laure Bañuls; Patrick Durand; Bettina Salle; Daniel Ajzenberg; Marie-Laure Dardé
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

Review 8.  Toxoplasma gondii and the blood-brain barrier.

Authors:  Sabrina M Feustel; Markus Meissner; Oliver Liesenfeld
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

Review 9.  Toxoplasmosis and epilepsy--systematic review and meta analysis.

Authors:  Edgard B Ngoungou; Devender Bhalla; Amandine Nzoghe; Marie-Laure Dardé; Pierre-Marie Preux
Journal:  PLoS Negl Trop Dis       Date:  2015-02-19

10.  Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana.

Authors:  Bernard Carme; Magalie Demar; Daniel Ajzenberg; Marie Laure Dardé
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more
  3 in total

1.  Cerebral toxoplasmosis diagnosed by brain tissue PCR analysis in an immunocompetent patient.

Authors:  Giuseppe Pustorino; Edoardo Ferlazzo; Maria Stella Carpentieri; Vittoria Cianci; Sara Gasparini; Mauro Campello; Giovanni Luigi Milardi; Antonio Gangemi; Umberto Aguglia
Journal:  Neurol Clin Pract       Date:  2017-10

2.  Toxoplasma Gondii Exposure and Neurological Disorders: An Age- and Gender-Matched Case-Control Pilot Study.

Authors:  Cosme Alvarado-Esquivel; Yazmin Del Rosario Rico-Almochantaf; Jesús Hernández-Tinoco; Gerardo Quiñones-Canales; Luis Francisco Sánchez-Anguiano; Jorge Torres-González; Björn Schott; Oliver Liesenfeld; Ildiko Rita Dunay
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-11-20

3.  A critical assessment of the association between postnatal toxoplasmosis and epilepsy in immune-competent patients.

Authors:  J W Uzorka; S M Arend
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-12       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.